|
Delayed
Toronto S.E.
11:31:11 2026-08-13 am EDT
|
5-day change | 1st Jan Change | ||
| 2.330 CAD | +9.91% |
|
+20.73% | +77.86% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 244.4 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 87.46% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 229.4 | 234.1 | 244.4 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 110.53% | 2.07% | 4.38% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -4.42x | -9.12x | 57.8x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 12x | 22.1x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | -0.2x | 0.2x | -0x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 73.6x | 6.73x |
| EV / Revenue | 1,803x | - | - | - | - | - | 70.5x | 6.73x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -8.92x | -14.7x | -11.9x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -6.54x | -8.71x | 50.7x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -11.3x | -50x | - |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -8.85% | -2% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.48 | -0.2325 | 0.0367 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 3.321 | 36.32 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -25.72 | -15.88 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -35.09 | -26.87 | 4.821 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -35.21 | -30.57 | -8.68 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -15.01 | -10.26 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 2.120 | 2.120 | 2.120 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 115,272 | - | - |
| Announcement Date | 3/23/22 | 3/28/23 | 4/1/24 | 3/31/25 | 3/31/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.42x | - | -8.92x | - | 176M | |
| 33.25x | 5.94x | 17.67x | 0.96% | 48.72B | |
| -21.3x | 291.14x | -21.61x | -.--% | 43.99B | |
| 47.03x | 5.44x | 29.75x | -.--% | 40.82B | |
| 31.13x | 3.08x | 13.29x | -.--% | 39.79B | |
| 30.74x | 8.86x | 22.27x | 0.38% | 32.7B | |
| 33.95x | 5.56x | 25.27x | -.--% | 16.66B | |
| 23.2x | 2.03x | 8.81x | 1.16% | 13.95B | |
| 76.09x | 4.01x | 15.56x | -.--% | 13.58B | |
| Average | 27.74x | 40.76x | 11.34x | 0.31% | 27.82B | |
| Weighted average by Cap. | 27.03x | 55.59x | 12.52x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
